Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: A phase 3 trial
- Xavier Forns
- , Eric Lawitz
- , Stefan Zeuzem
- , Ed Gane
- , Jean Pierre Bronowicki
- , Pietro Andreone
- , Andrzej Horban
- , Ashley Brown
- , Monika Peeters
- , Oliver Lenz
- , Sivi Ouwerkerk-Mahadevan
- , Jane Scott
- , Guy De La Rosa
- , Ronald Kalmeijer
- , Rekha Sinha
- , Maria Beumont-Mauviel
Research output: Contribution to journal › Article › peer-review
227
Link opens in a new tab
Scopus
citations